Machine Learning based prediction of Glucose Levels in Type 1 Diabetes Patients with the use of Continuous Glucose Monitoring Data

• URL: http://arxiv.org/abs/2302.12856v1
• Date: Fri, 24 Feb 2023 19:10:40 GMT
• Title: Machine Learning based prediction of Glucose Levels in Type 1 Diabetes Patients with the use of Continuous Glucose Monitoring Data
• Authors: Jakub J. Dylag
• Abstract summary: Continuous Glucose Monitoring (CGM) devices offer detailed, non-intrusive and real time insights into a patient's blood glucose concentrations. Leveraging advanced Machine Learning (ML) Models as methods of prediction of future glucose levels, gives rise to substantial quality of life improvements.
• Score: 0.0
• License: http://creativecommons.org/licenses/by-sa/4.0/
• Abstract: A task of vital clinical importance, within Diabetes management, is the prevention of hypo/hyperglycemic events. Increasingly adopted Continuous Glucose Monitoring (CGM) devices offer detailed, non-intrusive and real time insights into a patient's blood glucose concentrations. Leveraging advanced Machine Learning (ML) Models as methods of prediction of future glucose levels, gives rise to substantial quality of life improvements, as well as providing a vital tool for monitoring diabetes. A regression based prediction approach is implemented recursively, with a series of Machine Learning Models: Linear Regression, Hidden Markov Model, Long-Short Term Memory Network. By exploiting a patient's past 11 hours of blood glucose (BG) concentration measurements, a prediction of the 60 minutes is made. Results will be assessed using performance metrics including: Root Mean Squared Error (RMSE), normalised energy of the second-order differences (ESOD) and F1 score. Research of past and current approaches, as well as available dataset, led to the establishment of an optimal training methodology for the CITY dataset, which may be leveraged by future model development. Performance was aligned with similar state-of-art ML models, with LSTM having RMSE of 28.55, however no significant advantage was observed over classical Auto-regressive AR models. Compelling insights into LSTM prediction behaviour could increase public and legislative trust and understanding, progressing the certification of ML models in Artificial Pancreas Systems (APS).

Related papers

• AttenGluco: Multimodal Transformer-Based Blood Glucose Forecasting on AI-READI Dataset [8.063401183752347]
  Diabetes is a chronic metabolic disorder characterized by persistently high blood glucose levels (BGLs) Recent deep learning models show promise in improving BGL prediction. We propose AttenGluco, a multimodal Transformer-based framework for long-term blood glucose prediction.
  arXiv  Detail & Related papers  (2025-02-14T05:07:38Z)
• Towards Transparent and Accurate Diabetes Prediction Using Machine Learning and Explainable Artificial Intelligence [8.224338294959699]
  This study presents a framework for diabetes prediction using Machine Learning (ML) models and XAI tools. The ensemble model provided high accuracy, with a test accuracy of 92.50% and an ROC-AUC of 0.975. The results suggest that ML combined with XAI is a promising means of developing accurate and computationally transparent tools for use in healthcare systems.
  arXiv  Detail & Related papers  (2025-01-30T00:42:43Z)
• Let Curves Speak: A Continuous Glucose Monitor based Large Sensor Foundation Model for Diabetes Management [3.8195320624847833]
  Integrating AI with continuous glucose monitoring holds promise for near-future glucose prediction. CGM-LSM is pretrained on 15.96 million glucose records from 592 diabetes patients for near-future glucose prediction. LSM achieved exceptional performance, with an rMSE of 29.81 mg/dL for type 1 diabetes patients and 23.49 mg/dL for type 2 diabetes patients in a two-hour prediction horizon.
  arXiv  Detail & Related papers  (2024-12-12T21:35:13Z)
• From Glucose Patterns to Health Outcomes: A Generalizable Foundation Model for Continuous Glucose Monitor Data Analysis [47.23780364438969]
  We present GluFormer, a generative foundation model for CGM data that learns nuanced glycemic patterns and translates them into predictive representations of metabolic health. GluFormer generalizes to 19 external cohorts spanning different ethnicities and ages, 5 countries, 8 CGM devices, and diverse pathophysiological states. In a longitudinal study of 580 adults with CGM data and 12-year follow-up, GluFormer identifies individuals at elevated risk of developing diabetes more effectively than blood HbA1C%.
  arXiv  Detail & Related papers  (2024-08-20T13:19:06Z)
• Comparative Analysis of LSTM Neural Networks and Traditional Machine Learning Models for Predicting Diabetes Patient Readmission [0.0]
  This study uses the Diabetes 130-US Hospitals dataset for analysis and prediction of readmission patients by various machine learning models. LightGBM turned out to be the best traditional model, while XGBoost was the runner-up. This study demonstrates that model selection, validation, and interpretability are key steps in predictive healthcare modeling.
  arXiv  Detail & Related papers  (2024-06-28T15:06:22Z)
• MedDiffusion: Boosting Health Risk Prediction via Diffusion-based Data Augmentation [58.93221876843639]
  This paper introduces a novel, end-to-end diffusion-based risk prediction model, named MedDiffusion. It enhances risk prediction performance by creating synthetic patient data during training to enlarge sample space. It discerns hidden relationships between patient visits using a step-wise attention mechanism, enabling the model to automatically retain the most vital information for generating high-quality data.
  arXiv  Detail & Related papers  (2023-10-04T01:36:30Z)
• Clinical Deterioration Prediction in Brazilian Hospitals Based on Artificial Neural Networks and Tree Decision Models [56.93322937189087]
  An extremely boosted neural network (XBNet) is used to predict clinical deterioration (CD) The XGBoost model obtained the best results in predicting CD among Brazilian hospitals' data.
  arXiv  Detail & Related papers  (2022-12-17T23:29:14Z)
• Benchmarking Machine Learning Robustness in Covid-19 Genome Sequence Classification [109.81283748940696]
  We introduce several ways to perturb SARS-CoV-2 genome sequences to mimic the error profiles of common sequencing platforms such as Illumina and PacBio. We show that some simulation-based approaches are more robust (and accurate) than others for specific embedding methods to certain adversarial attacks to the input sequences.
  arXiv  Detail & Related papers  (2022-07-18T19:16:56Z)
• A multi-stage machine learning model on diagnosis of esophageal manometry [50.591267188664666]
  The framework includes deep-learning models at the swallow-level stage and feature-based machine learning models at the study-level stage. This is the first artificial-intelligence-style model to automatically predict CC diagnosis of HRM study from raw multi-swallow data.
  arXiv  Detail & Related papers  (2021-06-25T20:09:23Z)
• Interpreting Deep Glucose Predictive Models for Diabetic People Using RETAIN [4.692400531340393]
  We study the RETAIN architecture for the forecasting of future glucose values for diabetic people. Thanks to its two-level attention mechanism, the RETAIN model is interpretable while remaining as efficient as standard neural networks.
  arXiv  Detail & Related papers  (2020-09-08T13:20:15Z)
• Short Term Blood Glucose Prediction based on Continuous Glucose Monitoring Data [53.01543207478818]
  This study explores the use of Continuous Glucose Monitoring (CGM) data as input for digital decision support tools. We investigate how Recurrent Neural Networks (RNNs) can be used for Short Term Blood Glucose (STBG) prediction.
  arXiv  Detail & Related papers  (2020-02-06T16:39:44Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.